Phase II SRL
2.4 FTEThe score of Phase II shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -42 % Headcount (avg FTE) +41 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phase II's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −46,750 € | ||||
| Equity | −90,656 € | ||||
| Cash | 27,999 € | ||||
| EBITDA | 20,494 € | ||||
| Total assets | 214,989 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 09 Aug 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Phase II's financial analysis
- Solvency-42.2%sector median: 69.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phase II
Phase II's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0732.904.977
- VAT number
- BE0732904977
- Peppol
- Registered · 0208:0732904977 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Aug 2019
- Registered office
- 1180 Uccle
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- General medical practice activities (NACE 86210)
Phase II (SRL) has been based in Uccle since 2019, active in: general medical practice activities. For 2025, it reports a net loss of 46,750 € and equity of −90,656 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -42.2%, below the median of its sector (69.3%).
Companies similar to Phase II
Companies in the same business, of comparable size and area, outside its group.
- Dokbc General medical practice activities Saint-Gilles · balance sheet 355,354 €
- Medicine FOR Life General medical practice activities Saint-Josse-ten-Noode · balance sheet €1.34m
- Aida Lamrani General medical practice activities Brussels · balance sheet 41,699 €
- Indoloris Medical specialists activities Saint-Josse-ten-Noode · balance sheet 258,141 €
- Docteur Emilie GODINAS Medical specialists activities Esneux · balance sheet 193,848 €
- Cabinet Medical Boutrigui General medical practice activities Ans · balance sheet 647,789 €
- Dr PCT General medical practice activities Mons · balance sheet 189,689 €
- Dr. Melissa Vereecken - Oftalmologie General medical practice activities Merelbeke-Melle · balance sheet 273,609 €
Frequently asked questions about Phase II
What is the revenue of Phase II?
Phase II files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phase II?
In Belgium, the VAT number is the company number prefixed with BE: BE0732904977 for Phase II, if the company is VAT-registered. Its company number (CBE) is 0732.904.977.
Where is the registered office of Phase II?
According to the CBE register, the registered office of Phase II is in 1180 Uccle.
What is the equity of Phase II?
At the close of the 2025 financial year, the equity of Phase II amounts to -90,656 €, a solvency of -42.2% of total assets.
How many people work at Phase II?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phase II?
The register lists 1 active mandates at Phase II. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phase II
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →